BRIEF-Hubei Biocause Pharmaceutical's insurance unit posts premium income for Jan-Feb

March 13 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd

* Says insurance unit's premium income at 14.65 billion yuan

($2.12 billion) in Jan-Feb

Source text in Chinese: http://bit.ly/2nuOSLV

Further company coverage:

($1 = 6.9057 Chinese yuan renminbi)

(Reporting by Hong Kong newsroom)